Latest News | GlaxoSmithKline Board Okays VRS Scheme as Part of Biz Review

New Delhi, Nov 16 (PTI) GlaxoSmithKline Pharmaceuticals on Thursday said its board has approved a Voluntary Retirement Scheme (VRS) for a certain segment of employees under a strategic review of the business.

In a regulatory filing, the drug firm said its board has approved a commercial transformation initiative as part of a strategic review of the business.

Also Read | Chhattisgarh Assembly Elections 2023 Phase 2: When Is Voting and Result? How To Vote, Check Name in Voter List? How To Find Polling Station? Know Everything Here.

"As part of the transformation and to continue to remain competitive, the company will explore new innovative solutions, including omnichannel strategy, to expand its reach and coverage to the target segments," the drug firm said.

Further, the company has launched a voluntary retirement scheme for commercial function employees in field sales and head office.

Also Read | Cyclone Midhili Update by IMD: Deep Depression Over Bay of Bengal Likely To Intensify Into Cyclonic Storm and Cause Heavy Rainfall in Tamil Nadu and Kerala.

The initiative includes provisions for financial and transition support.

The financial impact will be communicated separately, GlaxoSmithKline Pharmaceuticals said.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)